期刊文献+

MiR-615-5p缓解Aβ25-35诱导的APOE4+/-型海马细胞的凋亡和变性

MiR-615-5p alleviates the apoptosis and degeneration of Aβ25-35-induced APOE4 + /-hippocampus cells
下载PDF
导出
摘要 目的探讨miR-615-5p对人海马细胞的凋亡和变性的影响及潜在机制。方法运用实时定量PCR检测正常、家族性AD和散发性AD老年人血液中miR-615-5p的表达水平,以及APOE4+/-型人胚海马细胞和Aβ诱导的APOE4+/-海马细胞中miR-615-5p的表达水平;在Aβ预处理的APOE4+/-型海马细胞中分别转染miR-615-5p mimic和inhibitor后检测细胞凋亡、氧化应激标志物含量和突触生长标志蛋白的表达水平;运用生物学信息分析和荧光素酶报告基因技术预测并验证mir-615-5p对APOE基因的靶定调控关系。结果散发性AD患者和细胞模型中miR-615-5p的表达水平显著下调;过表达miR-615-5p显著抑制海马细胞的凋亡和细胞内氧化应激,并促进细胞内突触生长蛋白的表达,而沉默miR-615-5p则作用相反;mir-615-5p可靶定结合APOE mRNA,并下调APOE4+/-海马细胞中APOE4蛋白的表达。结论 mir-615-5p通过靶向调节APOE,缓解Aβ25-35诱导的APOE4+/-型海马细胞的凋亡和变性。 Objective Apolipoprotein E4( apo E4) to explore the regulatory role and mechanism of miR-615-5p in the apoptosis and function of human hippocampus cells. Methods Expression of blood miR-615-5p were detected with real-time q PCR in familial Alzheimer's disease( AD) patients,sporadic AD patients and non-AD aged volunteers,as well as APOE4 + /- human embryonic hippocampus cells and Aβ-pretreated APOE4 + /-hippocampus cells; the mir-615-5p mimic or inhibitor was transfected into the Aβ-pretreated APOE4 + /-hippocampus cells,and then cell apoptosis,oxidative stress level and synaptic growth protein expression were detected; bioinformatics and luciferase reporter gene analyses were applied to evaluate and validate the targeting relationship between miR-615-5p and APOE4. Results MiR-615-5p was significantly decreased in sporadic AD patients and Aβ-pretreated APOE4 + /-hippocampus cells; mir-615-5p mimic transfection suppressed cell apoptosis and oxidative stress,and promoted the expression of synaptic growth proteins; in contrast,mir-615-5p inhibitor transfection had an opposite effect; APOE mRNA was targeted by mir-615-5p and APOE4 protein level in APOE4+ /-hippocampus cells was suppressed by mir-615-5p mimic transfection. Conclusion MiR-615-5p alleviates the apoptosis and degeneration of Aβ25-35-induced APOE4 + /-hippocampus cells.
出处 《中风与神经疾病杂志》 CAS 北大核心 2016年第6期540-544,共5页 Journal of Apoplexy and Nervous Diseases
关键词 mir-615-5p 阿尔茨海默病 载脂蛋白4 细胞凋亡 氧化应激 miR-615-5p Alzheimer's disease APOE4 Cell apoptosis Oxidative stress
  • 相关文献

参考文献21

  • 1Vinters HV, Emerging concepts in Alzheimer' s disease[ J]. Ann Rev Pathol,2015 (10) :291-319.
  • 2Baranello R, Bharani K, Padmaraju V, et al. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzhei- met' s disease[ J]. Current Alzheimer Res ,2015,12 ( 1 ) :32-46.
  • 3Jucker M, Walker LC. Neurodegeneration : Amyloid-beta pathology in- duced in humans[ J]. Nature ,2015,525 (7568) : 193-194.
  • 4Karch CM, Goate AM. Alzheimer' s disease risk genes and mechanisms of disease pathogenesis [ J ]. Biologic Psychiat ,2015,77 ( 1 ) :43-51.
  • 5Harapel H, Schneider kS,Giaeohini E,et al. Advances in the therapy of Alzheimer's disease:targeting amyloid beta and tau and perspectives for the future [ J ]. Expert Rev Neurotherapeutic ,2015,15 ( 1 ) : 83-105.
  • 6Lim Y, Villemagne V, Laws S, et al. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzhei- mer' s disease[ J]. Molecular Psychiat ,2015,20 ( 11 ) : 1322-1328.
  • 7Bonet-Costa V, Herranz-Perez V, Blanco-Gandia M, et al. Clearing Amyloid-β through PPARγ//ApoE activation by genistein is a treat- ment of experimental alzheimer' s disease [ J ]. J Alzheimer' s Dis, 2016(Preprint) : 1-11.
  • 8Daianu M, Mezher A, Jahanshad N, et al. Spectral graph theory and graph energy metrics show evidence for the Alzheimer' s disease dis- connection syndrome in APOE4 risk gene carriers[ J]. Proc IEEE Int Syrup Biomed Imaging,2015,4:458-461.
  • 9Boehm-Cagan A, Johansson JO, Bielicki JK, et al. Correction of ApoE4 dysfunction and reversal of Alzheimer' s disease phenotype and cognition in ApoE4 target replacement mice by cogpepb, an ab- cal agonist peptide derived from the lipid binding segment of ApoE [ J ]. Alzheimer' s & Dementia,2015,11 (7) :611-612.
  • 10Goodenowe DB, Senanayake V, Chitou B, et al. Relation of plasmalo- gens,ApoE genotype,and Alzheimer' s disease pathology to cogni- tion : A post-mortem analysis [ J ]. Alzheimer' s & Dementia, 2015, 11 (7) :865-866.

二级参考文献105

  • 1Ambros V. The functions of animal microRNAs. Na- ture,2004,431(7006) :350-355.
  • 2He L, Hannon GJ. MicroRNAs:small RNAs with a big role in gene regulation. Nat Rev Genet,2004,5(7):522- 531.
  • 3Bartel DP. MicroRNAs~ target recognition and regulato- ry functions. Cell, 2009,136 (2) : 215-233.
  • 4Barrel DP. MicroRNAs: genomics, biogenesis, mecha- nism, and function. Ce11,2004,116(2) :281-297.
  • 5Gangaraju VK, Lin H. MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol,2009,10(2):116-125.
  • 6Shi Y, Zhao X, Hsieh J, et al. MicroRNA regulation of neural stem cells and neurogenesis. J Neurosci, 2010,30 (45) : 14931-14936.
  • 7Ivey KN, Srivastava D. MicroRNAs as regulators of dif {erentiation and cell fate decisions. Cell Stem Cell, 2010, 7(1) :36-41.
  • 8Hulf T, Sibbritt T, Wiklund ED, et al. Discovery pipe line for epigenetically deregulated miRNAs in cancer integration of primary miRNA transcription. BMC Ge nomies,2011,12 : 54.
  • 9Soares MR, Huber J, Rios AF, et al. Investigation of IGF2/ApaI and H19/RsaI polymorphisms in patients with cutaneous melanoma. Growth Horm IGF Res,2010,20(4):295-297.
  • 10Jiang A, Zhang S, Li Z, et al. miR-615-3p promotes the phagocytic capacity of splenic macrophages by targe ting ligand-dependent nuclear receptor corepressor in cirrhosis related portal hypertension. Exp Biol Med (Maywood),2011,236(6) :672- 680.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部